Insights

Innovative Technology INOVOTION's unique chick embryo-based in vivo assays for anti-cancer efficacy and toxicity provide a faster, more cost-effective alternative to traditional preclinical testing, presenting an opportunity to upgrade or complement existing drug discovery pipelines.

Early Screening Advantage The company's focus on early target validation and multi-cancer screening allows pharmaceutical and biotech firms to make rapid Go/No Go decisions, streamlining R&D processes and reducing time-to-market for high-value oncology treatments.

Growing Market Visibility Participation in industry events like bio-europe and recent hires in R&D and Business Development suggest strategic growth efforts, making INOVOTION a compelling partner for companies seeking innovative preclinical testing solutions.

Cost-Effective Offerings With a focus on affordability and efficiency, INOVOTION's assays can appeal to smaller biotech firms and academic institutions with limited budgets, expanding potential sales channels in university research and early-stage biotech companies.

Market Expansion Potential Given its technological edge and recent strategic hires, there are opportunities to scale operations, enhance marketing outreach, and attract larger clients, positioning INOVOTION to grow within a competitive biotech testing market.

INOVOTION Tech Stack

INOVOTION uses 8 technology products and services including jQuery CDN, Google Fonts API, Modernizr, and more. Explore INOVOTION's tech stack below.

  • jQuery CDN
    Content Delivery Network
  • Google Fonts API
    Font Scripts
  • Modernizr
    Javascript Libraries
  • OVHcloud
    Platform As A Service
  • MonsterInsights
    Web Platform Extensions
  • Apache HTTP Server
    Web Servers
  • prettyPhoto
    Web Tools And Plugins
  • Google Plus
    Widgets

INOVOTION's Email Address Formats

INOVOTION uses at least 1 format(s):
INOVOTION Email FormatsExamplePercentage
First.Last@inovotion.comJohn.Doe@inovotion.com
46%
F.Last@inovotion.comJ.Doe@inovotion.com
4%
First.Last@inovotion.comJohn.Doe@inovotion.com
46%
F.Last@inovotion.comJ.Doe@inovotion.com
4%

Frequently Asked Questions

What is INOVOTION's official website and social media links?

Minus sign iconPlus sign icon
INOVOTION's official website is inovotion.com and has social profiles on LinkedInCrunchbase.

What is INOVOTION's SIC code NAICS code?

Minus sign iconPlus sign icon
INOVOTION's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does INOVOTION have currently?

Minus sign iconPlus sign icon
As of December 2025, INOVOTION has approximately 19 employees across 1 continents, including Europe. Key team members include Ceo: J. V.Chief Executive Officer: J. V.Head Of Business Development: P. F.. Explore INOVOTION's employee directory with LeadIQ.

What industry does INOVOTION belong to?

Minus sign iconPlus sign icon
INOVOTION operates in the Biotechnology Research industry.

What technology does INOVOTION use?

Minus sign iconPlus sign icon
INOVOTION's tech stack includes jQuery CDNGoogle Fonts APIModernizrOVHcloudMonsterInsightsApache HTTP ServerprettyPhotoGoogle Plus.

What is INOVOTION's email format?

Minus sign iconPlus sign icon
INOVOTION's email format typically follows the pattern of First.Last@inovotion.com. Find more INOVOTION email formats with LeadIQ.

When was INOVOTION founded?

Minus sign iconPlus sign icon
INOVOTION was founded in 2014.

INOVOTION

Biotechnology ResearchAuvergne-rhône-alpes, France11-50 Employees

INOVOTION is a biotech company which offers you a unique in vivo technology dedicated to anti-cancer treatment evaluations and early toxicity studies.

Our Fast, Sensitive, Reliable and Affordable assay will save you time and money, to give you a clear competitive advantage.

This breaking-thought technology, based on chick embryo, provides early analysis of your treatments before the classical preclinical stages. By eliminating low-value molecules early, INOVOTION accelerates your drug discovery process, increases your R&D productivity and reduces its costs. It’s rapid Go/No Go decision with multi-cancer screening capacities.

This next generation of in vivo efficacy and toxicity tests covers fours main aspects:
-	EFFICACY assays for your anti-cancer treatments
-	EARLY TOXICITY assays for your drug candidates
-	TARGET VALIDATION in oncology
-	MULTI-CANCER SCREENING to (re)positioning your treatment

We help chemists and biologists from companies and universities to validate a target and develop treatments by getting them through in vivo evaluation, while staying within their budget.

These accessible efficacy and toxicity assays open really new perspectives of screening for wide variety of project researches  with a rapid Go/No Go decisions.

You want focus your R&D on your high-value molecules, contact us!

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
11-50

Section iconFunding & Financials

  • $1M

    INOVOTION's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    INOVOTION's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.